Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKesson
Federal Trade Commission
Chinese Patent Office
QuintilesIMS
Cipla
Fish and Richardson
Baxter
McKinsey

Generated: July 15, 2018

DrugPatentWatch Database Preview

Etidocaine hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for etidocaine hydrochloride and what is the scope of etidocaine hydrochloride freedom to operate?

Etidocaine hydrochloride
is the generic ingredient in one branded drug marketed by Astrazeneca and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for etidocaine hydrochloride
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 37
Patent Applications: 3,914
DailyMed Link:etidocaine hydrochloride at DailyMed
Medical Subject Heading (MeSH) Categories for etidocaine hydrochloride
Synonyms for etidocaine hydrochloride
( inverted exclamation markA)-N-(2,6-dimethylphenyl)-2-(ethylpropylamino)butanamide Monohydrochloride
(.+/-.)-2-(Ethylpropylamino)-2',6'-butyroxylidide
(+-)-2-(Ethylpropylamino)-2',6'-butyroxylidide
(+-)-2-(N-Ethylpropylamino)-2',6'-butyroxylidide hydrochloride
(+-)-N-(2,6-Dimethylphenyl)-2-(ethylpropylamino)butanamide
(+/-)-N-(2,6-Dimethylphenyl)-2-(ethylpropylamino)butyramide monohydrochloride
(1)-N-(2,6-Dimethylphenyl)-2-(ethylpropylamino)butyramide monohydrochloride
[1-(2,6-dimethylanilino)-1-oxobutan-2-yl]-ethyl-propylazanium chloride
{1-[(2,6-DIMETHYLPHENYL)CARBAMOYL]PROPYL}(ETHYL)PROPYLAZANIUM CHLORIDE
1-[(2,6-dimethylphenyl)carbamoyl]propyl-ethyl-propyl-ammonium chloride
2-(Ethylpropylamino)-2',6'-butyroxylidide
2',6'-BUTYROXYLIDIDE, 2-(ETHYLPROPYLAMINO)-
2',6'-BUTYROXYLIDIDE, 2-(N-ETHYLPROPYLAMINO)-, HYDROCHLORIDE, (+-)-
36637-18-0
36637-19-1
38188-13-5
38188-14-6
38188-41-9
38188-42-0
60108-68-1
60YD32QL30
AC1L1XUQ
AC1L1XUT
AC1Q5LWD
AN-5631
API0002648
BC686212
BRN 2741181
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (-)-
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (.+/-.)-
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (+-)-
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (+)-
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, monohydrochloride, (-)-
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, monohydrochloride, (+-)-
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, monohydrochloride, (+-)- (9CI)
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, monohydrochloride, (+)-
C07530
C17H28N2O.HCl
CAS-36637-18-0
CHEBI:4904
CHEBI:4905
CHEMBL1200597
CHEMBL492
D00737
D04095
D0G7DJ
DB08987
DSSTox_CID_3027
DSSTox_GSID_23027
DSSTox_RID_76836
DTXSID1023027
Duranest
Duranest (TN)
Duranest Hydrochloride
EINECS 253-143-8
EINECS 253-144-3
Etidocaina
Etidocaina [INN-Spanish]
Etidocaine
Etidocaine (USAN/INN)
Etidocaine [USAN:BAN:INN]
Etidocaine [USAN:INN:BAN]
Etidocaine HCl
Etidocaine hydrochloride, (-)-
Etidocaine hydrochloride, (+)-
Etidocaine, (-)-
Etidocaine, (+)-
Etidocainum
Etidocainum [INN-Latin]
FT-0668418
FT-0696974
FT-0700005
GTPL2621
K9D2CE52PU
LP047928
LS-45490
LS-48493
LS-48494
N-(2,6-dimethylphenyl)-2-(ethyl-propylamino)butanamide
N-(2,6-Dimethylphenyl)-2-(ethylpropylamino)butanamide
N-(2,6-dimethylphenyl)-2-(ethylpropylamino)butanamide Hydrochloride
N-(2,6-Dimethylphenyl)-2-(N-ethyl-N-propylamino)butyramide
N-(2,6-dimethylphenyl)-2-[ethyl(propyl)amino]butanamide
NCGC00183654-01
OR063134
OR066745
OR263344
OR263345
SC-51047
SCHEMBL419100
SCHEMBL57261
Tox21_112968
UNII-60YD32QL30
UNII-K9D2CE52PU
UNII-Y83XVY9AQ8
UNII-YGD0Y35434
VTUSIVBDOCDNHS-UHFFFAOYSA-N
W 19053
W-19053
W-19053 [AS HYDROCHLORIDE]
Y83XVY9AQ8
YGD0Y35434

US Patents and Regulatory Information for etidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca DURANEST etidocaine hydrochloride INJECTABLE;INJECTION 017751-005 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca DURANEST etidocaine hydrochloride INJECTABLE;INJECTION 017751-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for etidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca DURANEST etidocaine hydrochloride INJECTABLE;INJECTION 017751-005 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Astrazeneca DURANEST etidocaine hydrochloride INJECTABLE;INJECTION 017751-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Astrazeneca DURANEST etidocaine hydrochloride INJECTABLE;INJECTION 017751-005 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Astrazeneca DURANEST etidocaine hydrochloride INJECTABLE;INJECTION 017751-005 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Teva
Harvard Business School
Cantor Fitzgerald
Mallinckrodt
Deloitte
Baxter
Chubb
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.